Special report on an overdose cluster in St. Louis; new theory on cause of unusual hepatitis cases in kids

A cluster of overdose deaths in St. Louis captures how the drug epidemic has taken on new dangers and is claiming different sets of victims. ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Sponsored by      Two deadly days in St. Louis: An overdose cluster kills 8 Black people — and shows the new shape of the addiction crisis By Andrew Joseph Michael Thomas for STAT A cluster of overdose deaths in St. Louis captures how the drug epidemic has taken on new dangers and is claiming different sets of victims. Read More New studies offer theory on cause of unusual hepatitis cases in kids By Helen Branswell CDC/ Dr. R. Haraszti The papers may help to explain why some medical centers have seen what appear to be unusual numbers of cases of unexplained hepatitis. Read More STAT+: Four brain-computer interface companies you should watch (other than Neuralink) By Elissa Welle Courtesy Paradromics, Inc. Away from the limelight, a handful of companies have been gaining momentum in the race to commercialize their brain-computer interface. Read More Sponsor content by PhRMA 340B is helping big hospitals & chain pharmacies The 340B program was designed to help patients. Instead, it has become less about patients and more about boosting the bottom lines of big hospitals and chain pharmacies. Large hospitals buy deeply discounted 340B medicines and then turn around and charge both uninsured patients and insurance companies higher prices, pocketing the difference with little to no evidence they use that money to help those who actually need it. Does that seem fair to patients? Learn more. White House to launch effort to develop next generation of Covid vaccines By Matthew Herper and Lev Facher NIAID/NIH The Biden administration is kicking off the effort with a summit featuring federal officials, top scientists, and pharmaceutical executives. Read More STAT+: A troubling report on Cerner's VA rollout offers a rare look into the hidden harms of health records By Katie Palmer Adobe The rollout of Cerner’s electronic health record in VA hospitals has been plagued by problems. They underscore the hidden harms of EHRs. Read More Opinion: Demanding more impact from impact litigation: lessons to be learned from multi-state opioid settlements By Reuben Guttman and Liza Vertinsky Seth Wenig/AP The massive opioid-related settlements won by state Attorneys General should be industry-changing events. Secrecy will thwart that. Read More Collateral damage of the Fed's interest rate hikes: People who put medical bills on credit cards By Bob Herman Adobe Under new federal monetary policy, patients who put their medical bills on credit cards will likely be saddled with higher interest rates. Read More Opinion: Working with Indigenous allies is the ethical way to develop psychedelic-based pharmaceuticals By Jeeshan Chowdhury ALFREDO ESTRELLA/AFP via Getty Images Indigenous peoples pioneered the use of psychedelics. They should benefit from the rush to make and sell psychedelic pharmaceuticals. Read More Monday, July 25, 2022       1 Exchange Pl, Suite 201, Boston, MA 02109 ©2022, All Rights Reserved. I no longer wish to receive STAT emails Update Email Preferences | Contact Us | View In Browser